Brian Wehrle’s Post

📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eRBrcDtQ #artificialintelligence #clinicaltrials #ophthalmology

📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eJYY7Rgf #artificialintelligence #clinicaltrials #ophthalmology

📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/dv-5-y3R #artificialintelligence #clinicaltrials #ophthalmology

Cool stuff for eCOA and Imaging in ophthalmology research! 📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eYh52nv7 #artificialintelligence #clinicaltrials #ophthalmology

📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://hubs.li/Q02CD4gL0 #artificialintelligence #clinicaltrials #ophthalmology

📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://hubs.li/Q02CD4gL0 #artificialintelligence #clinicaltrials #ophthalmology

🎥 Engage with Dr. Peter Kaiser (Cleveland Clinic Lerner Research Institute) at COPHy Congress, a conference renowned for its debate style, where he delves into the future of ophthalmology. Discover his enthusiasm for the intersection of AI and anti-VEGF therapies, particularly the role of biomarkers and machine learning in predicting patient outcomes and treatment needs. Dr. Kaiser shares his insights on how these advancements could revolutionize patient care, offering personalized approaches that could predict the number of injections a patient might need—a breakthrough in our current understanding. #COPHY2024 #OphthalmologyInnovation #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy 

🎥 Discover the cutting-edge integration of AI in ophthalmology with Dr. Kenneth Fan (Retina Consultants of Texas)! In our latest feature from COPHy Congress, Simrat Sodhi & Dr. Fan explores the dynamic role of AI in enhancing imaging and treatment, particularly focusing on geographic atrophy and macular degeneration. Learn how AI-driven tools are identifying patients who could benefit most from innovative treatments like anti-complement medications, paving the way for personalized care and improved outcomes. Don't miss Dr. Fan's insights on the future of AI in predicting disease progression and transforming patient care in ophthalmology. #COPHY2024 #AIinOphthalmology #retina #geographicatrophy #maculardegeneration #OphthalmologyInsights #MedicalInnovation

World Sight Day 2024: Experts weigh-in on potential impact of AI in diagnostics and screening. On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and finding diseases in the future. Watch: https://ow.ly/1NLq50TJ2Pn

As a passionate advocate for cutting-edge medical technology, I'm thrilled by the performance of RadiusXR, a game-changer in the field of visual field testing. 💡 Let's dive into the technical differentiators: 1️⃣ Precision Engineering: Unlike other virtual reality perimeters (VRPs) that repurpose consumer-grade gaming headsets, RadiusXR is meticulously designed and manufactured specifically for ophthalmology. This ensures optimal performance and reliability, giving clinicians the assurance they need in their diagnostic tools. 🔬 2️⃣ Unparalleled Accuracy: Our NOVA Clinical Trial has demonstrated a remarkable 0.94 correlation in mean deviation and statistical non-inferiority for glaucoma staging compared to traditional methods. This level of accuracy is a game-changer in diagnosing and managing ocular conditions, empowering clinicians with actionable insights to improve patient outcomes. 📊Read the peer-reviewed publication in the Journal of Translational Vision Science and Technology published by the Association for Research in Vision and Ophthalmology (ARVO). 3️⃣ Photopic Range Measurement: One of our key differentiators is our ability to measure vision within the photopic range, aligning perfectly with existing visual field platforms' standards. This ensures consistent clinical training and facilitates comparison to patients' prior examinations, ultimately enhancing outcomes. 🌟 4️⃣ Innovation in Action: RadiusXR is not just pushing boundaries but redefining them. This technology combines spatial computing with precision engineering to deliver unparalleled accuracy and reliability. From glaucoma staging to monitoring disease progression, RadiusXR is paving the way for a brighter future in ocular health. #RadiusXR #Innovation #OcularHealth #MedicalTechnology #VisionaryTech